Both early and chronic inflammation are therapeutic targets in brain trauma. New PET radioligands allow targeting of several key components of the CNS inflammation. This talk will review the emerging PET tracers for neuroinflammation, and consider them in the context of experimental traumatic brain injury, temporal disease progression, and available MRI and MRS approaches.
This abstract and the presentation materials are available to members only; a login is required.